WELLINGTON MANAGEMENT GROUP LLP - TETRALOGIC PHARMACEUTICALS C ownership

TETRALOGIC PHARMACEUTICALS C's ticker is TLOG and the CUSIP is 88165U109. A total of 31 filers reported holding TETRALOGIC PHARMACEUTICALS C in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of TETRALOGIC PHARMACEUTICALS C
ValueSharesWeighting
Q3 2015$208,000
-32.5%
110,580
-15.9%
0.00%
Q2 2015$308,000
-46.5%
131,4900.0%0.00%
Q1 2015$576,000
-17.8%
131,490
-9.5%
0.00%
Q4 2014$701,000
+5.1%
145,360
-9.3%
0.00%
Q3 2014$667,000
-29.3%
160,3000.0%0.00%
Q2 2014$944,000
-7.7%
160,3000.0%0.00%
Q1 2014$1,023,000
-74.9%
160,300
-62.6%
0.00%
-100.0%
Q4 2013$4,077,000428,3000.00%
Other shareholders
TETRALOGIC PHARMACEUTICALS C shareholders Q4 2015
NameSharesValueWeighting ↓
Clarus Ventures, LLC 4,644,705$8,593,0004.94%
First Washington CORP 319,250$591,0000.36%
Burt Wealth Advisors 2,625$4,0000.01%
MYCIO WEALTH PARTNERS, LLC 12,000$22,0000.01%
Weiss Multi-Strategy Advisers LLC 31,500$59,0000.00%
Alyeska Investment Group, L.P. 92,225$171,0000.00%
First Eagle Investment Management, LLC 325,559$612,0000.00%
HighTower Advisors, LLC 61,514$114,0000.00%
Cannell & Co. 11,713$22,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 18,553$35,0000.00%
View complete list of TETRALOGIC PHARMACEUTICALS C shareholders